Hyderabad India; April 11, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, announced the
Dr. Reddy’s named by Science Magazine among Top 20 employers in pharma globally for second year in a row
Hyderabad, India; November 1, 2023 – Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) announced that the prestigious Science Magazine has ranked the company among its Top 20 Employers list in pharma,
Dr. Reddy’s Announces Launch of D2C E-Commerce Website ‘Celevida Wellness’ for Diabetes
India; October 26, 2023 – Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by